[1]CurrentPatentAssignee:CHINESEACADEMYOFMEDICALSCIENCES-CN103450134,2017,BLocationinpatent:Paragraph0024;0140;0144
[2]Locationinpatent:experimentalpartAzizian,Javad;Mohammadi,AliA.;Bidar,Ilyar;Mirzaei,Peiman[MonatsheftefurChemie,2008,vol.139,#7,p.805-808]
[3]Mirjalili,BiBiFatemeh;Bamoniri,Abdolhamid;Fazeli-Attar,SeyedeAzita[ResearchonChemicalIntermediates,2022,vol.48,#2,p.839-851]
[4]Rodriguez-Dominguez,JuanC.;Kirsch,Gilbert[Synthesis,2006,#11,p.1895-1897]
[5]Rodríguez-Domínguez,JuanCarlos;Kirsch,Gilbert[TetrahedronLetters,2006,vol.47,#19,p.3279-3281]
[6]Dey[JournaloftheChemicalSociety,1915,vol.107,p.1637]
[7]Chakravarti[JournaloftheIndianChemicalSociety,1931,vol.8,p.407][JournaloftheIndianChemicalSociety,1935,vol.12,p.536,539]
[8]Locationinpatent:experimentalpartLi,Gang;Wang,Dongmei;Sun,Mingna;Li,Guangyan;Hu,Jinfeng;Zhang,Yun;Yuan,Yuhe;Ji,Haijie;Chen,Naihong;Liu,Gang[JournalofMedicinalChemistry,2010,vol.53,#4,p.1741-1754]
Title: Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.
Journal: Journal of medicinal chemistry 20100225
